Related Experiment Video

Updated: Feb 19, 2026

Isolation of Rat Portal Fibroblasts by In situ Liver Perfusion
07:39

Isolation of Rat Portal Fibroblasts by In situ Liver Perfusion

Published on: June 29, 2012

19.8K

[Transforming growth factor-β1 small interfering RNA regulates platelet-derived growth factor and phosphorylated

X F Zhou1, Y J Jiang1, Y Zhang1

  • 1Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|November 7, 2017
PubMed

Insights

Targeted silencing of transforming growth factor-β1 (TGF-β1) using small interfering RNA (siRNA) effectively reduced platelet-derived growth factor-BB (PDGF-BB) and its receptor (PDGF-βR) in rats with liver fibrosis. This approach also inhibited p-ERK1/2 expression, suggesting a therapeutic benefit for hepatic fibrosis.

Area of Science:

  • Hepatology
  • Molecular Biology
  • RNA Interference Therapeutics

Background:

  • Hepatic fibrosis is a significant health concern characterized by excessive extracellular matrix deposition in the liver.
  • Transforming growth factor-β1 (TGF-β1) is a key mediator in the pathogenesis of liver fibrosis.
  • Platelet-derived growth factor-BB (PDGF-BB) and its receptor (PDGF-βR) signaling pathways are implicated in fibrotic processes.

Purpose of the Study:

  • To investigate the effect of TGF-β1 silencing via small interfering RNA (siRNA) on PDGF-BB and PDGF-βR expression in a rat model of hepatic fibrosis.
  • To evaluate the impact of TGF-β1 siRNA on the downstream signaling molecule phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2).

Main Methods:

  • A rat model of hepatic fibrosis was established using carbon tetrachloride injection.
  • Rats were treated with TGF-β1 siRNA or a negative control via tail vein injection.
  • Liver tissue expression of PDGF-BB, PDGF-βR, and p-ERK1/2 was quantified using real-time PCR, immunohistochemistry, and Western blot.

Main Results:

  • TGF-β1 siRNA treatment significantly inhibited the mRNA and protein expression of PDGF-BB and PDGF-βR compared to control groups.
  • Expression of p-ERK1/2 was also significantly downregulated in the TGF-β1 siRNA treatment group.
  • These findings indicate successful targeted inhibition of key fibrotic mediators.

Conclusions:

  • Targeted silencing of TGF-β1 using siRNA effectively downregulates PDGF-BB, PDGF-βR, and p-ERK1/2 expression in liver tissue.
  • This downregulation suggests a potential therapeutic strategy for improving hepatic fibrosis.
  • TGF-β1 siRNA represents a promising approach for managing liver fibrosis progression.
Keywords:
Extracellular regulated protein kinaseHepatic cirrhosisPlatelet-derived growth factorTransforming growth factor-beta 1

More Related Videos

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

11.1K
Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

9.6K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.7K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K